

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | rRNA modification (GO:0000154) | 5.67582099 |
| 2 | rRNA methylation (GO:0031167) | 5.49121142 |
| 3 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 5.27972850 |
| 4 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 5.27972850 |
| 5 | DNA deamination (GO:0045006) | 4.82582864 |
| 6 | proteasome assembly (GO:0043248) | 4.70282962 |
| 7 | folic acid-containing compound biosynthetic process (GO:0009396) | 4.49436800 |
| 8 | purine nucleotide salvage (GO:0032261) | 4.18681883 |
| 9 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.78182480 |
| 10 | ribosome assembly (GO:0042255) | 3.77556620 |
| 11 | IMP biosynthetic process (GO:0006188) | 3.76361476 |
| 12 | adenosine metabolic process (GO:0046085) | 3.74669274 |
| 13 | DNA double-strand break processing (GO:0000729) | 3.73159350 |
| 14 | pseudouridine synthesis (GO:0001522) | 3.58706493 |
| 15 | protein-cofactor linkage (GO:0018065) | 3.56059393 |
| 16 | CENP-A containing nucleosome assembly (GO:0034080) | 3.55241208 |
| 17 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.49757525 |
| 18 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.48955472 |
| 19 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.46530228 |
| 20 | protein complex biogenesis (GO:0070271) | 3.42058922 |
| 21 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.40666658 |
| 22 | mitochondrial RNA metabolic process (GO:0000959) | 3.39541290 |
| 23 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.38934103 |
| 24 | histone exchange (GO:0043486) | 3.38657431 |
| 25 | ribosome biogenesis (GO:0042254) | 3.37353205 |
| 26 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.35063042 |
| 27 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.35063042 |
| 28 | NADH dehydrogenase complex assembly (GO:0010257) | 3.35063042 |
| 29 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.34311360 |
| 30 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.33214743 |
| 31 | GTP biosynthetic process (GO:0006183) | 3.32831059 |
| 32 | chromatin remodeling at centromere (GO:0031055) | 3.32454587 |
| 33 | tRNA modification (GO:0006400) | 3.31953536 |
| 34 | tRNA processing (GO:0008033) | 3.27110508 |
| 35 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.25648378 |
| 36 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.24929455 |
| 37 | DNA ligation (GO:0006266) | 3.19362605 |
| 38 | IMP metabolic process (GO:0046040) | 3.19009376 |
| 39 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.18639514 |
| 40 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.18639514 |
| 41 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.18639514 |
| 42 | platelet dense granule organization (GO:0060155) | 3.18101146 |
| 43 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.17130795 |
| 44 | purine nucleobase biosynthetic process (GO:0009113) | 3.16250189 |
| 45 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.15698370 |
| 46 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.15698370 |
| 47 | L-serine metabolic process (GO:0006563) | 3.15320067 |
| 48 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.13809679 |
| 49 | positive regulation of prostaglandin secretion (GO:0032308) | 3.13107010 |
| 50 | positive regulation of mitochondrial fission (GO:0090141) | 3.10966682 |
| 51 | protein polyglutamylation (GO:0018095) | 3.09787973 |
| 52 | positive regulation of endothelial cell differentiation (GO:0045603) | 3.09631417 |
| 53 | purine-containing compound salvage (GO:0043101) | 3.07809582 |
| 54 | amino acid salvage (GO:0043102) | 3.07663396 |
| 55 | L-methionine salvage (GO:0071267) | 3.07663396 |
| 56 | L-methionine biosynthetic process (GO:0071265) | 3.07663396 |
| 57 | homocysteine metabolic process (GO:0050667) | 3.05883250 |
| 58 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.05835976 |
| 59 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.05071009 |
| 60 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.05071009 |
| 61 | DNA catabolic process, exonucleolytic (GO:0000738) | 3.03403786 |
| 62 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.02583678 |
| 63 | negative regulation of ligase activity (GO:0051352) | 3.02583678 |
| 64 | respiratory chain complex IV assembly (GO:0008535) | 3.02500536 |
| 65 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.01728813 |
| 66 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.99238894 |
| 67 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.99089010 |
| 68 | replication fork processing (GO:0031297) | 2.93325773 |
| 69 | cytidine deamination (GO:0009972) | 2.92378189 |
| 70 | cytidine metabolic process (GO:0046087) | 2.92378189 |
| 71 | cytidine catabolic process (GO:0006216) | 2.92378189 |
| 72 | response to pheromone (GO:0019236) | 2.91934660 |
| 73 | chaperone-mediated protein transport (GO:0072321) | 2.90977332 |
| 74 | establishment of integrated proviral latency (GO:0075713) | 2.90733121 |
| 75 | sperm motility (GO:0030317) | 2.88702302 |
| 76 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.87569108 |
| 77 | nucleobase biosynthetic process (GO:0046112) | 2.86328376 |
| 78 | sperm-egg recognition (GO:0035036) | 2.86047737 |
| 79 | UTP metabolic process (GO:0046051) | 2.84210693 |
| 80 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.83924988 |
| 81 | negative regulation of B cell apoptotic process (GO:0002903) | 2.83530681 |
| 82 | RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502) | 2.82752777 |
| 83 | cell wall macromolecule catabolic process (GO:0016998) | 2.82028206 |
| 84 | rRNA processing (GO:0006364) | 2.77177680 |
| 85 | positive regulation of ligase activity (GO:0051351) | 2.76295665 |
| 86 | sulfur amino acid catabolic process (GO:0000098) | 2.75867433 |
| 87 | serine family amino acid catabolic process (GO:0009071) | 2.75475881 |
| 88 | serine family amino acid biosynthetic process (GO:0009070) | 2.73215162 |
| 89 | DNA damage response, detection of DNA damage (GO:0042769) | 2.72998281 |
| 90 | tRNA metabolic process (GO:0006399) | 2.72604588 |
| 91 | CTP metabolic process (GO:0046036) | 2.71837471 |
| 92 | CTP biosynthetic process (GO:0006241) | 2.71837471 |
| 93 | cysteine metabolic process (GO:0006534) | 2.71379770 |
| 94 | UTP biosynthetic process (GO:0006228) | 2.70631655 |
| 95 | GMP metabolic process (GO:0046037) | 2.68922144 |
| 96 | sulfur amino acid biosynthetic process (GO:0000097) | 2.68846346 |
| 97 | rRNA metabolic process (GO:0016072) | 2.68749074 |
| 98 | termination of RNA polymerase III transcription (GO:0006386) | 2.67700600 |
| 99 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.67700600 |
| 100 | mannosylation (GO:0097502) | 2.66356315 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 7.98934171 |
| 2 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.77166936 |
| 3 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.13399795 |
| 4 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.58649373 |
| 5 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.50221362 |
| 6 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.44210203 |
| 7 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.09606771 |
| 8 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.89442471 |
| 9 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.85901248 |
| 10 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.69888342 |
| 11 | VDR_22108803_ChIP-Seq_LS180_Human | 2.68685803 |
| 12 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.64563332 |
| 13 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.61091187 |
| 14 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.47790820 |
| 15 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.29007492 |
| 16 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.26450362 |
| 17 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.21817063 |
| 18 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.13647710 |
| 19 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.09019439 |
| 20 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.90602919 |
| 21 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.85753429 |
| 22 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.85582561 |
| 23 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.79740800 |
| 24 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.76447155 |
| 25 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.72047559 |
| 26 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.69379146 |
| 27 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.69364401 |
| 28 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.68251060 |
| 29 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.67006854 |
| 30 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.66785889 |
| 31 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.64340660 |
| 32 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.62205523 |
| 33 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.58762976 |
| 34 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.55510082 |
| 35 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.54599902 |
| 36 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.46002541 |
| 37 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.45436736 |
| 38 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.42569939 |
| 39 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.42531024 |
| 40 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.35516543 |
| 41 | EWS_26573619_Chip-Seq_HEK293_Human | 1.33057123 |
| 42 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.32215040 |
| 43 | FUS_26573619_Chip-Seq_HEK293_Human | 1.32177627 |
| 44 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.31310923 |
| 45 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.28534806 |
| 46 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.28212989 |
| 47 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.25985086 |
| 48 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.25325940 |
| 49 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.22927774 |
| 50 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.22104951 |
| 51 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.20362607 |
| 52 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.20170446 |
| 53 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.19008037 |
| 54 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.18814742 |
| 55 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.18361885 |
| 56 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.17472367 |
| 57 | P300_19829295_ChIP-Seq_ESCs_Human | 1.15394046 |
| 58 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.15130059 |
| 59 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.08577863 |
| 60 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.07733348 |
| 61 | NCOR_22424771_ChIP-Seq_293T_Human | 1.07045322 |
| 62 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.06126540 |
| 63 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.05543666 |
| 64 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.04963182 |
| 65 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.04364278 |
| 66 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.04364278 |
| 67 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.03831718 |
| 68 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.01725204 |
| 69 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.99792398 |
| 70 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.99582252 |
| 71 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.98721689 |
| 72 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.97949316 |
| 73 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.97692412 |
| 74 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.97636894 |
| 75 | AR_20517297_ChIP-Seq_VCAP_Human | 0.97489269 |
| 76 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.94825041 |
| 77 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.94825041 |
| 78 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.93601692 |
| 79 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.93488265 |
| 80 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.93170391 |
| 81 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.91211630 |
| 82 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.91071535 |
| 83 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.90895741 |
| 84 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.90895741 |
| 85 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.90079586 |
| 86 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.89847195 |
| 87 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.89832191 |
| 88 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.89251219 |
| 89 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88325035 |
| 90 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.88219048 |
| 91 | GATA3_26560356_Chip-Seq_TH2_Human | 0.87982306 |
| 92 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.87830353 |
| 93 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.87551642 |
| 94 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.87460848 |
| 95 | ERA_21632823_ChIP-Seq_H3396_Human | 0.87160335 |
| 96 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.86731287 |
| 97 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.85266950 |
| 98 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.83887307 |
| 99 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.83464385 |
| 100 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.82300958 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008995_early_reproductive_senescence | 3.25732156 |
| 2 | MP0002138_abnormal_hepatobiliary_system | 3.15989611 |
| 3 | MP0005410_abnormal_fertilization | 2.93850399 |
| 4 | MP0008058_abnormal_DNA_repair | 2.87688021 |
| 5 | MP0006292_abnormal_olfactory_placode | 2.71834894 |
| 6 | MP0003693_abnormal_embryo_hatching | 2.71493566 |
| 7 | MP0003718_maternal_effect | 2.60880437 |
| 8 | MP0002736_abnormal_nociception_after | 2.55609463 |
| 9 | MP0009697_abnormal_copulation | 2.54064417 |
| 10 | MP0003806_abnormal_nucleotide_metabolis | 2.51970329 |
| 11 | MP0005084_abnormal_gallbladder_morpholo | 2.48187429 |
| 12 | MP0003786_premature_aging | 2.45197817 |
| 13 | MP0002102_abnormal_ear_morphology | 2.43577638 |
| 14 | MP0004147_increased_porphyrin_level | 2.38536523 |
| 15 | MP0010094_abnormal_chromosome_stability | 2.34435171 |
| 16 | MP0000516_abnormal_urinary_system | 2.30485777 |
| 17 | MP0005367_renal/urinary_system_phenotyp | 2.30485777 |
| 18 | MP0005360_urolithiasis | 2.26583496 |
| 19 | MP0004957_abnormal_blastocyst_morpholog | 2.21183689 |
| 20 | MP0008877_abnormal_DNA_methylation | 2.08756846 |
| 21 | MP0005646_abnormal_pituitary_gland | 2.02297910 |
| 22 | MP0001661_extended_life_span | 1.97682731 |
| 23 | MP0003183_abnormal_peptide_metabolism | 1.87753459 |
| 24 | MP0001764_abnormal_homeostasis | 1.87681265 |
| 25 | MP0002139_abnormal_hepatobiliary_system | 1.78564852 |
| 26 | MP0002876_abnormal_thyroid_physiology | 1.77955611 |
| 27 | MP0006072_abnormal_retinal_apoptosis | 1.72598040 |
| 28 | MP0001929_abnormal_gametogenesis | 1.69304367 |
| 29 | MP0002837_dystrophic_cardiac_calcinosis | 1.68935361 |
| 30 | MP0008872_abnormal_physiological_respon | 1.68325333 |
| 31 | MP0003186_abnormal_redox_activity | 1.66897955 |
| 32 | MP0004885_abnormal_endolymph | 1.62752992 |
| 33 | MP0001968_abnormal_touch/_nociception | 1.57617810 |
| 34 | MP0005085_abnormal_gallbladder_physiolo | 1.55187663 |
| 35 | MP0005379_endocrine/exocrine_gland_phen | 1.47971820 |
| 36 | MP0002938_white_spotting | 1.47062818 |
| 37 | MP0003111_abnormal_nucleus_morphology | 1.45539242 |
| 38 | MP0002163_abnormal_gland_morphology | 1.45218035 |
| 39 | MP0003698_abnormal_male_reproductive | 1.44510029 |
| 40 | MP0005670_abnormal_white_adipose | 1.39324363 |
| 41 | MP0005551_abnormal_eye_electrophysiolog | 1.37777469 |
| 42 | MP0000372_irregular_coat_pigmentation | 1.36272468 |
| 43 | MP0005253_abnormal_eye_physiology | 1.34170258 |
| 44 | MP0005645_abnormal_hypothalamus_physiol | 1.28059959 |
| 45 | MP0003077_abnormal_cell_cycle | 1.28034113 |
| 46 | MP0003646_muscle_fatigue | 1.23481058 |
| 47 | MP0002210_abnormal_sex_determination | 1.20099989 |
| 48 | MP0008007_abnormal_cellular_replicative | 1.19377606 |
| 49 | MP0001293_anophthalmia | 1.17979935 |
| 50 | MP0005671_abnormal_response_to | 1.17670531 |
| 51 | MP0002148_abnormal_hypersensitivity_rea | 1.16084659 |
| 52 | MP0001145_abnormal_male_reproductive | 1.09451609 |
| 53 | MP0006276_abnormal_autonomic_nervous | 1.08989816 |
| 54 | MP0004782_abnormal_surfactant_physiolog | 1.07931893 |
| 55 | MP0003195_calcinosis | 1.07858912 |
| 56 | MP0002277_abnormal_respiratory_mucosa | 1.05987703 |
| 57 | MP0003315_abnormal_perineum_morphology | 1.05720036 |
| 58 | MP0000653_abnormal_sex_gland | 1.05539284 |
| 59 | MP0006035_abnormal_mitochondrial_morpho | 1.04348506 |
| 60 | MP0003011_delayed_dark_adaptation | 1.03594580 |
| 61 | MP0000613_abnormal_salivary_gland | 1.01591959 |
| 62 | MP0002234_abnormal_pharynx_morphology | 0.97730465 |
| 63 | MP0006036_abnormal_mitochondrial_physio | 0.96830087 |
| 64 | MP0008875_abnormal_xenobiotic_pharmacok | 0.96679817 |
| 65 | MP0005167_abnormal_blood-brain_barrier | 0.94520395 |
| 66 | MP0000647_abnormal_sebaceous_gland | 0.93679274 |
| 67 | MP0003724_increased_susceptibility_to | 0.92747313 |
| 68 | MP0005365_abnormal_bile_salt | 0.90746093 |
| 69 | MP0005332_abnormal_amino_acid | 0.90603932 |
| 70 | MP0001963_abnormal_hearing_physiology | 0.90184015 |
| 71 | MP0002095_abnormal_skin_pigmentation | 0.90067660 |
| 72 | MP0008932_abnormal_embryonic_tissue | 0.88806755 |
| 73 | MP0002735_abnormal_chemical_nociception | 0.88464801 |
| 74 | MP0003252_abnormal_bile_duct | 0.87421962 |
| 75 | MP0000465_gastrointestinal_hemorrhage | 0.87141686 |
| 76 | MP0005636_abnormal_mineral_homeostasis | 0.87101265 |
| 77 | MP0001919_abnormal_reproductive_system | 0.85969990 |
| 78 | MP0008789_abnormal_olfactory_epithelium | 0.85815757 |
| 79 | MP0005647_abnormal_sex_gland | 0.85183514 |
| 80 | MP0000049_abnormal_middle_ear | 0.83348745 |
| 81 | MP0005075_abnormal_melanosome_morpholog | 0.82571332 |
| 82 | MP0009764_decreased_sensitivity_to | 0.80490792 |
| 83 | MP0005187_abnormal_penis_morphology | 0.79154783 |
| 84 | MP0000631_abnormal_neuroendocrine_gland | 0.77884538 |
| 85 | MP0001984_abnormal_olfaction | 0.77357460 |
| 86 | MP0002161_abnormal_fertility/fecundity | 0.73848467 |
| 87 | MP0003878_abnormal_ear_physiology | 0.73497260 |
| 88 | MP0005377_hearing/vestibular/ear_phenot | 0.73497260 |
| 89 | MP0002282_abnormal_trachea_morphology | 0.73320811 |
| 90 | MP0001346_abnormal_lacrimal_gland | 0.71794866 |
| 91 | MP0005389_reproductive_system_phenotype | 0.71321675 |
| 92 | MP0001119_abnormal_female_reproductive | 0.70347116 |
| 93 | MP0002160_abnormal_reproductive_system | 0.70309013 |
| 94 | MP0000013_abnormal_adipose_tissue | 0.68763839 |
| 95 | MP0001502_abnormal_circadian_rhythm | 0.66709308 |
| 96 | MP0008775_abnormal_heart_ventricle | 0.65643860 |
| 97 | MP0002396_abnormal_hematopoietic_system | 0.65545747 |
| 98 | MP0005083_abnormal_biliary_tract | 0.63875784 |
| 99 | MP0000026_abnormal_inner_ear | 0.63864470 |
| 100 | MP0005319_abnormal_enzyme/_coenzyme | 0.63795214 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of alanine metabolism (HP:0010916) | 4.67587890 |
| 2 | Hyperalaninemia (HP:0003348) | 4.67587890 |
| 3 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 4.67587890 |
| 4 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 4.01890858 |
| 5 | Constricted visual fields (HP:0001133) | 3.94605232 |
| 6 | Attenuation of retinal blood vessels (HP:0007843) | 3.57792947 |
| 7 | Abnormality of serum amino acid levels (HP:0003112) | 3.43777654 |
| 8 | Acute encephalopathy (HP:0006846) | 3.08891432 |
| 9 | Abolished electroretinogram (ERG) (HP:0000550) | 3.08002044 |
| 10 | Increased CSF lactate (HP:0002490) | 3.03347535 |
| 11 | Mitochondrial inheritance (HP:0001427) | 3.00969348 |
| 12 | Hepatocellular necrosis (HP:0001404) | 2.99217086 |
| 13 | Acute necrotizing encephalopathy (HP:0006965) | 2.99061787 |
| 14 | Hyperglycinemia (HP:0002154) | 2.96211849 |
| 15 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.95194848 |
| 16 | Chronic hepatic failure (HP:0100626) | 2.89567962 |
| 17 | Increased serum lactate (HP:0002151) | 2.87776664 |
| 18 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.72504552 |
| 19 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.72504552 |
| 20 | 3-Methylglutaconic aciduria (HP:0003535) | 2.71106264 |
| 21 | Generalized aminoaciduria (HP:0002909) | 2.70636795 |
| 22 | Methylmalonic acidemia (HP:0002912) | 2.70297108 |
| 23 | Retinal dysplasia (HP:0007973) | 2.69796998 |
| 24 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.69463437 |
| 25 | Hepatic necrosis (HP:0002605) | 2.61912005 |
| 26 | Lipid accumulation in hepatocytes (HP:0006561) | 2.56088667 |
| 27 | Increased hepatocellular lipid droplets (HP:0006565) | 2.50442198 |
| 28 | Lactic acidosis (HP:0003128) | 2.49367711 |
| 29 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.47652368 |
| 30 | Absent/shortened dynein arms (HP:0200106) | 2.47652368 |
| 31 | Decreased central vision (HP:0007663) | 2.41513183 |
| 32 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.40976752 |
| 33 | Reduced antithrombin III activity (HP:0001976) | 2.40274557 |
| 34 | Degeneration of anterior horn cells (HP:0002398) | 2.39359313 |
| 35 | Abnormality of the anterior horn cell (HP:0006802) | 2.39359313 |
| 36 | Cone-rod dystrophy (HP:0000548) | 2.36403748 |
| 37 | Pendular nystagmus (HP:0012043) | 2.35309348 |
| 38 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.33717167 |
| 39 | Methylmalonic aciduria (HP:0012120) | 2.32384057 |
| 40 | Cerebral edema (HP:0002181) | 2.31905000 |
| 41 | Aplastic anemia (HP:0001915) | 2.31402391 |
| 42 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.29221818 |
| 43 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.26366844 |
| 44 | Increased intramyocellular lipid droplets (HP:0012240) | 2.24279711 |
| 45 | Abnormality of the labia minora (HP:0012880) | 2.22144490 |
| 46 | Congenital sensorineural hearing impairment (HP:0008527) | 2.22052912 |
| 47 | Type I transferrin isoform profile (HP:0003642) | 2.21803345 |
| 48 | Abnormality of midbrain morphology (HP:0002418) | 2.19897516 |
| 49 | Molar tooth sign on MRI (HP:0002419) | 2.19897516 |
| 50 | Progressive macrocephaly (HP:0004481) | 2.19659298 |
| 51 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.17977318 |
| 52 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.17977318 |
| 53 | Pancreatic cysts (HP:0001737) | 2.17661934 |
| 54 | Renal Fanconi syndrome (HP:0001994) | 2.17233073 |
| 55 | Type II lissencephaly (HP:0007260) | 2.17123572 |
| 56 | Type 2 muscle fiber atrophy (HP:0003554) | 2.16036379 |
| 57 | Glycosuria (HP:0003076) | 2.13166380 |
| 58 | Abnormality of urine glucose concentration (HP:0011016) | 2.13166380 |
| 59 | Optic disc pallor (HP:0000543) | 2.09953107 |
| 60 | Keratoconus (HP:0000563) | 2.09049623 |
| 61 | Increased corneal curvature (HP:0100692) | 2.09049623 |
| 62 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.05432125 |
| 63 | Abnormality of homocysteine metabolism (HP:0010919) | 2.01281205 |
| 64 | Homocystinuria (HP:0002156) | 2.01281205 |
| 65 | Abnormality of glycine metabolism (HP:0010895) | 2.00978044 |
| 66 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.00978044 |
| 67 | Conjunctival telangiectasia (HP:0000524) | 1.99684693 |
| 68 | Tubulointerstitial nephritis (HP:0001970) | 1.99406294 |
| 69 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.99348171 |
| 70 | True hermaphroditism (HP:0010459) | 1.96337685 |
| 71 | Increased serum pyruvate (HP:0003542) | 1.95294920 |
| 72 | Abnormality of methionine metabolism (HP:0010901) | 1.95262423 |
| 73 | Abnormal ciliary motility (HP:0012262) | 1.93793027 |
| 74 | Lethargy (HP:0001254) | 1.92910893 |
| 75 | Hyperphosphaturia (HP:0003109) | 1.92866488 |
| 76 | Increased muscle lipid content (HP:0009058) | 1.91961844 |
| 77 | Intestinal atresia (HP:0011100) | 1.89539677 |
| 78 | Chorioretinal atrophy (HP:0000533) | 1.88915638 |
| 79 | White forelock (HP:0002211) | 1.88555803 |
| 80 | IgG deficiency (HP:0004315) | 1.88101785 |
| 81 | Nephronophthisis (HP:0000090) | 1.87945752 |
| 82 | Muscle fiber atrophy (HP:0100295) | 1.87374903 |
| 83 | Cerebral hypomyelination (HP:0006808) | 1.84653048 |
| 84 | Pancytopenia (HP:0001876) | 1.83073540 |
| 85 | Patchy hypopigmentation of hair (HP:0011365) | 1.82554480 |
| 86 | Volvulus (HP:0002580) | 1.81575887 |
| 87 | Delayed CNS myelination (HP:0002188) | 1.79774969 |
| 88 | Chromsome breakage (HP:0040012) | 1.79547312 |
| 89 | Pancreatic fibrosis (HP:0100732) | 1.78181655 |
| 90 | Abnormality of the ileum (HP:0001549) | 1.75692732 |
| 91 | Hyperglycinuria (HP:0003108) | 1.74672242 |
| 92 | Medial flaring of the eyebrow (HP:0010747) | 1.74415960 |
| 93 | Abnormal protein glycosylation (HP:0012346) | 1.73983263 |
| 94 | Abnormal glycosylation (HP:0012345) | 1.73983263 |
| 95 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.73983263 |
| 96 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.73983263 |
| 97 | Poor speech (HP:0002465) | 1.73699606 |
| 98 | Colon cancer (HP:0003003) | 1.72810569 |
| 99 | Meckel diverticulum (HP:0002245) | 1.72250824 |
| 100 | Metabolic acidosis (HP:0001942) | 1.72139571 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 4.37457293 |
| 2 | ZAK | 3.07401922 |
| 3 | TLK1 | 2.67516041 |
| 4 | BCKDK | 2.66222025 |
| 5 | MAP4K2 | 2.59225802 |
| 6 | TESK2 | 2.50570018 |
| 7 | BUB1 | 2.45386891 |
| 8 | NUAK1 | 2.41914360 |
| 9 | MST4 | 2.40224155 |
| 10 | EIF2AK3 | 2.28901810 |
| 11 | VRK1 | 2.27436774 |
| 12 | TIE1 | 2.27257028 |
| 13 | SRPK1 | 2.21279351 |
| 14 | CCNB1 | 2.09942174 |
| 15 | WNK3 | 2.06377585 |
| 16 | PLK4 | 1.99218245 |
| 17 | ACVR1B | 1.87098080 |
| 18 | KDR | 1.77012859 |
| 19 | TSSK6 | 1.74098961 |
| 20 | PINK1 | 1.67314877 |
| 21 | GRK1 | 1.62334640 |
| 22 | BMPR1B | 1.46273903 |
| 23 | TRIM28 | 1.45287288 |
| 24 | CDC7 | 1.44343858 |
| 25 | ADRBK2 | 1.40625942 |
| 26 | PLK3 | 1.40193366 |
| 27 | BCR | 1.34264447 |
| 28 | INSRR | 1.33470651 |
| 29 | DAPK1 | 1.30416161 |
| 30 | TAF1 | 1.29767027 |
| 31 | CSNK1G3 | 1.28257729 |
| 32 | WNK4 | 1.26101717 |
| 33 | STK38L | 1.12573165 |
| 34 | PLK2 | 1.08048075 |
| 35 | PBK | 1.07987521 |
| 36 | CSNK1G1 | 1.04563972 |
| 37 | RPS6KA4 | 1.04414466 |
| 38 | CSNK1A1L | 1.00555672 |
| 39 | TESK1 | 1.00227186 |
| 40 | NEK9 | 0.98830055 |
| 41 | CSNK1G2 | 0.98492315 |
| 42 | DYRK2 | 0.98084662 |
| 43 | TNIK | 0.97574231 |
| 44 | STK16 | 0.96039857 |
| 45 | ATR | 0.94115254 |
| 46 | CDK8 | 0.92527165 |
| 47 | STK39 | 0.92441751 |
| 48 | CDK9 | 0.91268614 |
| 49 | OXSR1 | 0.91053782 |
| 50 | PLK1 | 0.90116230 |
| 51 | WEE1 | 0.88894076 |
| 52 | NME1 | 0.86365585 |
| 53 | EIF2AK1 | 0.85925608 |
| 54 | TXK | 0.82128445 |
| 55 | MKNK1 | 0.81148237 |
| 56 | FGR | 0.80413626 |
| 57 | RPS6KA5 | 0.79438983 |
| 58 | PDK2 | 0.78534400 |
| 59 | TEC | 0.77221472 |
| 60 | NEK1 | 0.75316256 |
| 61 | MAPK13 | 0.73355339 |
| 62 | CDK7 | 0.71055281 |
| 63 | FRK | 0.71037869 |
| 64 | CSNK1A1 | 0.69341682 |
| 65 | AURKA | 0.66505487 |
| 66 | IKBKB | 0.63886396 |
| 67 | FES | 0.60852299 |
| 68 | EIF2AK2 | 0.60410879 |
| 69 | PRKCQ | 0.59158231 |
| 70 | ERBB3 | 0.58746558 |
| 71 | CSNK2A1 | 0.55989391 |
| 72 | MKNK2 | 0.54497471 |
| 73 | NME2 | 0.54161783 |
| 74 | MAPKAPK3 | 0.54142144 |
| 75 | AURKB | 0.53967177 |
| 76 | CSNK2A2 | 0.51922031 |
| 77 | GRK7 | 0.49535577 |
| 78 | RPS6KB2 | 0.48850286 |
| 79 | TAOK3 | 0.48568189 |
| 80 | OBSCN | 0.47481290 |
| 81 | CHEK2 | 0.46950787 |
| 82 | PNCK | 0.43632645 |
| 83 | ATM | 0.43368409 |
| 84 | PIK3CG | 0.42063627 |
| 85 | JAK3 | 0.41951427 |
| 86 | ADRBK1 | 0.41566278 |
| 87 | PRKD3 | 0.41515293 |
| 88 | PHKG2 | 0.41140776 |
| 89 | PHKG1 | 0.41140776 |
| 90 | MAPKAPK5 | 0.40401563 |
| 91 | SCYL2 | 0.40100254 |
| 92 | NEK2 | 0.37934620 |
| 93 | MAP3K12 | 0.34850344 |
| 94 | CASK | 0.34071398 |
| 95 | NEK6 | 0.33561579 |
| 96 | MAP2K7 | 0.32853862 |
| 97 | PRKCA | 0.29868899 |
| 98 | CDK4 | 0.28437111 |
| 99 | PRKCE | 0.28041216 |
| 100 | CHEK1 | 0.27952356 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 4.47096489 |
| 2 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.84078385 |
| 3 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.77296672 |
| 4 | RNA polymerase_Homo sapiens_hsa03020 | 2.39714658 |
| 5 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.38017125 |
| 6 | Mismatch repair_Homo sapiens_hsa03430 | 2.31006068 |
| 7 | Homologous recombination_Homo sapiens_hsa03440 | 2.26094421 |
| 8 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.20932371 |
| 9 | DNA replication_Homo sapiens_hsa03030 | 2.15509690 |
| 10 | Protein export_Homo sapiens_hsa03060 | 2.03870240 |
| 11 | Basal transcription factors_Homo sapiens_hsa03022 | 1.95815115 |
| 12 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.94278394 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.92913653 |
| 14 | Parkinsons disease_Homo sapiens_hsa05012 | 1.92404044 |
| 15 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.91973160 |
| 16 | Spliceosome_Homo sapiens_hsa03040 | 1.86112809 |
| 17 | Base excision repair_Homo sapiens_hsa03410 | 1.85973858 |
| 18 | RNA transport_Homo sapiens_hsa03013 | 1.79460343 |
| 19 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.75910155 |
| 20 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.64764286 |
| 21 | RNA degradation_Homo sapiens_hsa03018 | 1.63153773 |
| 22 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.62427243 |
| 23 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.61068404 |
| 24 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.57822276 |
| 25 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.56768359 |
| 26 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.53120690 |
| 27 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.48135139 |
| 28 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.38046135 |
| 29 | Peroxisome_Homo sapiens_hsa04146 | 1.35092438 |
| 30 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.33979757 |
| 31 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.33552260 |
| 32 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.30497537 |
| 33 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.28308587 |
| 34 | Purine metabolism_Homo sapiens_hsa00230 | 1.27033431 |
| 35 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.25348009 |
| 36 | Huntingtons disease_Homo sapiens_hsa05016 | 1.24370878 |
| 37 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.14856714 |
| 38 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.13996465 |
| 39 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.13955886 |
| 40 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.13209705 |
| 41 | Ribosome_Homo sapiens_hsa03010 | 1.11421955 |
| 42 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.10641604 |
| 43 | Phototransduction_Homo sapiens_hsa04744 | 1.09787788 |
| 44 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.06118474 |
| 45 | Allograft rejection_Homo sapiens_hsa05330 | 1.03020119 |
| 46 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.02709906 |
| 47 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.02392741 |
| 48 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.01477273 |
| 49 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.01058160 |
| 50 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.00117825 |
| 51 | Alzheimers disease_Homo sapiens_hsa05010 | 0.96431171 |
| 52 | Carbon metabolism_Homo sapiens_hsa01200 | 0.96048897 |
| 53 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.92833001 |
| 54 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.89945181 |
| 55 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.88519127 |
| 56 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.87056029 |
| 57 | Retinol metabolism_Homo sapiens_hsa00830 | 0.84370712 |
| 58 | Olfactory transduction_Homo sapiens_hsa04740 | 0.84284890 |
| 59 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.83267587 |
| 60 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.82462738 |
| 61 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.80359269 |
| 62 | Sulfur relay system_Homo sapiens_hsa04122 | 0.79328990 |
| 63 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.78712732 |
| 64 | Asthma_Homo sapiens_hsa05310 | 0.77772133 |
| 65 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.77057472 |
| 66 | Metabolic pathways_Homo sapiens_hsa01100 | 0.75555329 |
| 67 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.75460981 |
| 68 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.74328823 |
| 69 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.73579999 |
| 70 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.72891449 |
| 71 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.71054467 |
| 72 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.69418008 |
| 73 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.68310485 |
| 74 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.66057688 |
| 75 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.63205841 |
| 76 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.62289825 |
| 77 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.61151459 |
| 78 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.59714456 |
| 79 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.57401161 |
| 80 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.56187401 |
| 81 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.54181837 |
| 82 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.50805147 |
| 83 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.50399915 |
| 84 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.49710195 |
| 85 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.49396091 |
| 86 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.49002457 |
| 87 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.48274819 |
| 88 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.47174174 |
| 89 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.46261809 |
| 90 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.45232158 |
| 91 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.43598101 |
| 92 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.43468875 |
| 93 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.42271422 |
| 94 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.41312158 |
| 95 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.39539941 |
| 96 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.38423496 |
| 97 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.38138478 |
| 98 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.37778258 |
| 99 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.37754311 |
| 100 | Taste transduction_Homo sapiens_hsa04742 | 0.36346118 |

